The Lassa Virus is an acute illness caused by a single-stranded RNA arena virus of the family Arenaviridae. As a zoonotic disease, it affects humans only when they are infected or come into contact with the virus. In addition to being in close contact with rat excreta and blood, this fever can be spread through contaminated food and water. Lassa Virus patients commonly experience fever, general weakness, and malaise at the beginning of the illness. There are a number of symptoms associated with this disease, including headaches, sore throats, muscle pains, chest pains, nausea, vomiting, diarrhea, coughing, and abdominal discomfort. Poor hygiene and sanitation facilities are more common in rural areas and dwellings. Lassa virus is commonly treated with ribavirin, an antiviral drug. Market drivers include the increasing number of patients affected by Lassa Virus, its increasing prevalence, and an increase in the percentage mortality caused by Lassa Virus. There is a greater risk of death from Lassa virus in its late stages compared to its early stages. Technology advancements such as multidisciplinary research and development activities being conducted consistently for the development of a novel drug, recent modifications to immunodiagnostics kits to enhance the efficacy of current treatment options, and increasing public awareness of Lassa Virus are also expected to boost the Lassa Virus market. During the forecast period, however, the Lassa Virus Market is expected to be hampered by a lack of skilled professionals and manpower involved in treating the disease, a lack of healthcare infrastructure due to unorganized sales and distribution, and the difficulty of diagnosing patients based on initial infection symptoms and clinical presentations. Lassa Virus market is also driven by multidisciplinary research and development activities aimed at developing novel drugs and improving rapid immunodiagnostics kits in order to improve the efficacy of current treatment options for the virus as a whole in order to save lives. Lassa Virus Market growth may be hindered by the shortage of skilled professionals, poor healthcare infrastructure and difficulty in diagnosing patients based on clinical presentation in emerging countries.
FutureWise Market Research has instantiated a report that provides an intricate analysis of Lassa Virus Market trends that shall affect the overall market growth. Furthermore, it includes detailed information on the graph of profitability, SWOT analysis, market share and regional proliferation of this business. Moreover, the report offers insights on the current stature of prominent market players in the competitive landscape analysis of this market.
According to the research study conducted by FutureWise research analysts, the Lassa Virus Market is anticipated to attain substantial growth by the end of the forecast period. The report explains that this business is predicted to register a noteworthy growth rate over the forecast period. This report provides crucial information pertaining to the total valuation that is presently held by this industry and it also lists the segmentation of the market along with the growth opportunities present across this business vertical.